# Classifying superconductivity in compressed H3S

Article · E. F. Talantsev

- Archive id: arxiv:1902.01772
- Published: 2019-02-05
- Venue: Modern Physics Letters B 33, 1950195 (2019)
- DOI: https://doi.org/10.1142/s0217984919501951
- arXiv: https://arxiv.org/abs/1902.01772
- Citations: 43
- Source URL: https://arxiv.org/abs/1902.01772
- PDF: https://arxiv.org/pdf/1902.01772
- Provenance: arxiv

## Abstract

The discovery of high-temperature superconductivity in compressed H3S by Drozdov and co-workers (A. Drozdov, et. al., Nature 525, 73 (2015)) heralded a new era in superconductivity. To date, the record transition temperature of Tc = 260 K stands with another hydrogen-rich compound, LaH10 (M. Somayazulu, et. al., arXiv:1808.07695) which becomes superconducting at pressure of P = 190 GPa. Despite very intensive first-principle theoretical studies of hydrogen-rich compounds compressed to megabar level pressure, there is a very limited experimental dataset available for such materials. In this paper, we analyze the upper critical field, Bc2(T), data of highly compressed H3S reported by Mozaffari and co-workers (S. Mozaffari, et. al., LA-UR-18-30460, DOI: 10.2172/1481108) by utilizing four different models of Bc2(T). In result, we find that the ratio of superconducting energy gap, Δ(0), to the Fermi energy, εF, in all considered scenarios is 0.03 \< Δ(0)/εF \< 0.07, with respective ratio of Tc to the Fermi temperature, TF, 0.012 \< Tc/TF \< 0.039. These characterize H3S as unconventional superconductor and places it on the same trend line in Tc versus TF plot, where all unconventional superconductors located.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Superconducting Hydrides Under Pressure](https://space-kitty.com/topics/hydride-superconductors)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
